Clicking moves left

Enhanced Elimination in Toxicology

Enhanced Elimination in Toxicology Extracorporeal eliminationExtracorpore [...]

Decontamination in Toxicology

Decontamination in ToxicologyorHow to Decontamination in ToxicologySingle-dose [...]

Resuscitation in Toxicology

Resuscitation in ToxicologySupportive careInitial resuscitation should be based [...]

Key investigations of Toxicology

Key investigations of Toxicology In this topic: Electrocardiography Drug conce [...]

Arterial blood gases in Toxicology

Arterial blood gases in Toxicology Arterial blood gases are an important in [...]

Clicking moves right
M O V I E
TRAVELING

Pharmacology of Disopyramide Indication For the treatment of documented ventricular arrhythmias, such as [...]

Pharmacology of Ranolazine Indication For the treatment of chronic angina. It should be used in combinati [...]

Pharmacology of Milrinone Indication Indicated for the treatment of congestive heart failure. Pharma [...]

Pharmacology of Midodrine   Indication For the treatment of symptomatic orthostatic hypotension [...]

Pharmacology of Dofetilide  Indication For the maintenance of normal sinus rhythm (delay in time to [...]

GALLERY

Anxiety disorders may be classified asgeneralized anxiety disorder, panic disorder, obsessive-compu [...]

Post-Traumatic Stress DisorderPost-traumatic stress disorder develops following a traumatic event that elicit [...]

Social Anxiety DisorderSocial anxiety disorder, formerly known as social phobia, is characterized by an inten [...]

TOP LINE

Anxiety disorders may be classified asgeneralized anxiety disorder, panic disorder, obsessive-compulsive disorder, social anxiety disorder, post-traumatic stress disorder. Click to view each type....

REVIEW

Hormonal contraceptivesHormonal contraceptives inhibit ovulation. Contraceptives typically contain a combination of hormones. Fo...

Erectile dysfunction therapy drugsErectile dysfunction therapy drugs treat penile erectile dysfunction that results from a lack ...

Urinary tract antispasmodicsUrinary tract antispasmodics help decrease urinary tract muscle spasms. They include darifenacin, fl...

ANALYSIS

Pharmacology of Disopyramide Indication For the treatment of documented ventricular arrhythmias, such as sustained ventricul...

Pharmacology of Ranolazine Indication For the treatment of chronic angina. It should be used in combination with amlodipine, ...

Pharmacology of Milrinone Indication Indicated for the treatment of congestive heart failure. Pharmacodynamics Milri...

HIGHLIGHT
[ more from label ]
Classification of Anxiety Disorders
Post-Traumatic Stress Disorder
Social Anxiety Disorder
Obsessive-Compulsive Disorder
Latest News Updates
PERFORMANCE

Pharmacology of Disopyramide Indication For the treatment of documented ventricular arrhythmias, such as ...

FEATURE

Anxiety disorders may be classified asgeneralized anxiety disorder, panic disorder, obsessive-compu...

Toxicology: beta blockers
Monday, October 3, 2011 Posted by Piscean


Toxicology: beta blockers

For pharmacological information, see Beta blockers in 'Getting to know your drugs'.
Indicators of toxicity
Dose ingested
No clear toxic dose has been identified except for propranolol where ingestions of more than 2 g are associated with seizures.

Other factors determining toxicity of beta blockers
There are a number of important risk factors in beta blocker poisoning:
type of beta blocker:
propranolol: CNS effects, class IA anti-arrhythmic properties
sotalol: more severe cardiac effects and QT prolongation
patient's age or underlying heart disease
co-ingestion of calcium antagonist or digoxin.
Clinical presentation
The presenting features include:
central nervous system effects: seizures, delirium and coma occur with lipophilic beta blockers such as propranolol 
 
cardiovascular effects: Hypotension is due to a combination of myocardial depression and bradycardia. The most common arrhythmia is sinus bradycardia. In severe cases there can be 1st to 3rd degree heart block, junctional bradycardia, ventricular bradycardia and asystole.
metabolic effects: hypoglycaemia. 
 
Key investigations
ECG: QRS widening can occur with propranolol poisoning, (see QRS widening) and QT prolongation with sotalol (see QT prolongation).
blood glucose level.
Treatment
Airway and breathing
Ensure that there is an adequate airway and breathing. However, intubation and ventilation are usually only required with severe poisoning, where a decreased level of consciousness is multifactorial (hypoxia, hypotension, direct drug effect).
Coma and seizures are common with severe propranolol poisoning and will require early intervention.

Circulation
Hypotension should be treated with a fluid bolus of 20 mL/kg of normal saline. Use:
sodium chloride 0.9% 20 mL/kg IV, over 10 to 30 minutes.
This should be repeated if there is no response or only a partial response. Persistent hypotension will need to be treated with inotropes, see Inotropic support.
Serial ECGs and ECG monitoring should be done in all but minor poisonings with beta blockers. Bradycardia can be treated with atropine if there is hypotension, use:
atropine 0.5 to 1.5 mg IV as a bolus; repeat after 15 minutes if necessary (child: 0.02 mg/kg to a maximum of 0.5 mg/dose IV, repeated in 5 minutes if required to a total maximum of 1 mg).

Severe bradycardia with persistent hypotension may require temporary transvenous pacing.
Torsades de pointes may occur with sotalol poisoning and the QT interval should be measured regularly. Torsades de pointes should be treated with a 200 J DC shock and then isoprenaline or transvenous pacing, but magnesium should be avoided due to its potential to cause calcium channel blockade. In adults, use:
isoprenaline 20 micrograms IV, repeat according to clinical response, and commence an infusion at 1 to 4 micrograms/minute (see Box 14.5). The rate may need to be rapidly increased to give double, quadruple or higher doses as required to overcome beta blockade. 


Inotropic support
There is considerable controversy over inotropes in beta-blocker poisoning and advice from a clinical toxicologist should be obtained early. Although glucagon is often recommended there is no evidence to support its effectiveness, and there is rarely enough glucagon kept in hospitals to maintain treatment for over an hour. Recent animal evidence suggests vasopressors do not improve outcomes, so adrenaline, noradrenaline and vasopressin should be avoided in isolation. The following inotropes are recommended based on animal studies and anecdotal experience. In adults, use:
1
isoprenaline 20 micrograms IV, repeat according to clinical response (up to 100 micrograms), and commence an infusion at 2 to 4 micrograms/minute (see Box 14.5). The rate may need to be rapidly increased to give double, quadruple or higher doses as required to overcome beta blockade. Isoprenaline can be given via a peripheral line


OR


1
short-acting insulin 1 unit/kg (see Table 5.30) IV as an initial bolus, followed by an infusion at 1 unit/kg/hour IV. The dose can be increased to 2 units/kg/hour or further but this should be discussed with a clinical toxicologist



PLUS

glucose 50% 50 mL (child: glucose 10% 2.5 mL/kg) IV as an initial bolus, followed by an infusion according to Box 14.26

OR


2
glucagon 5 to 10 mg (= 5 to 10 units) IV as an initial bolus, followed by an infusion at 5 to 10 mg/hour IV

OR

2
milrinone 50 micrograms/kg IV, slowly over 10 minutes, followed by an infusion of 0.375 to 0.75 micrograms/kg/minute IV, adjusting according to clinical and haemodynamic response, up to a maximum of 1.13 mg/kg daily [Note 1].

Vasopressors such as metaraminol or low-dose adrenaline may be useful in the short term if there is evidence of reduced systemic vascular resistance with the use of insulin or isoprenaline. However, they should not be used in patients with the poor perfusion typical of untreated beta blocker poisoning. In adults, use:
1
adrenaline 1 mg IV as a bolus; this can be repeated every 2 to 5 minutes depending on clinical response. An adrenaline infusion should then be commenced. See Box 14.4.


OR
2
metaraminol 0.5 to 1 mg IV as an initial bolus; this can be repeated if there is a clinical response.

If the patient has a cardiac arrest, prolonged cardiopulmonary resuscitation should be undertaken (4 to 8 hours), as prior to the overdose these patients are usually healthy individuals. Cardiac assist devices and/or extracorporeal circulatory support should be considered if available.
Decontamination
Consider an initial dose of charcoal up to two hours after the estimated time of ingestion in severe poisoning if the patient has a protected airway. Use:
activated charcoal 50 g (child: 1 g/kg to a maximum of 50 g) orally or via orogastric or nasogastric tube, within 2 hours of the estimated time of ingestion. Patients must be able to protect their airway or be intubated.

Caution: In the setting of beta blocker overdose, atropine should be administered prior to the insertion of a nasogastric tube to prevent further bradycardia due to vagal stimulation. Use:
atropine 300 to 600 micrograms (child: 0.02 mg/kg to a maximum of 0.5 mg/dose) IV.

Specific pharmacological therapies
Anticonvulsant therapy
Treat underlying hypoglycaemia, see below.
Persistent seizures seen in propranolol poisoning should initially be treated with benzodiazepines. For drug and dosing recommendations, see Anticonvulsant therapy.
Treatment of hypoglycaemia
Hypoglycaemia should be treated. Use:
glucose 50% 50 mL (child: glucose 10% 2.5 mL/kg) IV, as an initial bolus.
Monitoring and disposition
Criteria for admission: All patients with deliberate self-poisoning or patients unintentionally ingesting more than the daily dose of beta blockers should be assessed initially and observed for at least six hours.

Piscean

Thanks for your visit..!

0 comments for "Toxicology: beta blockers"

Leave a reply